Dr Reddys Laboratories receives EIR for Bachupally facility
(20 May 2020)
Dr Reddys Laboratories announced that its formulations manufacturing plant - 3 at Bachupally, Hyderabad has received Establishment Inspection Report from USFDA, indicating closure of audit.